Outcomes of stereotactic radiosurgery in young adults with vestibular schwannomas

J Neurooncol. 2021 Aug;154(1):93-100. doi: 10.1007/s11060-021-03803-w. Epub 2021 Jul 9.

Abstract

Purpose: Vestibular schwannomas (VSs) are comparatively rare in younger patients, and stereotactic radiosurgery (SRS) outcome data are limited. We aimed to evaluate long-term SRS outcomes concerning sporadic VSs in patients aged ≤ 40 years.

Methods: Of 383 patients with VS who had undergone SRS at our institution between 1990 and 2017, we retrospectively compared younger and older patients' tumor control and radiation-induced complication rates using case-control propensity score (PS) matching.

Results: The mean follow-up was 83 and 92 months in older and younger patients, respectively. Compared with older patients, younger patients were more likely to have a history of resection (20% vs. 39%, p = 0.006) and be treated with higher marginal doses (median, 12 Gy vs. 14 Gy; p = 0.014). Cumulative 5- and 10-year tumor control rates were higher in older patients (97.7% and 93.9%, respectively) than in younger patients (90.2% and 85.4%, respectively, p = 0.024). After PS matching, younger patients' cumulative tumor control rates (93.6%, 85.4%, and 85.4% at 5, 10, and 15 years, respectively) were similar to those of older patients (p = 0.411). No significant between-cohort differences in hearing preservation rates or other cranial nerve complications were observed. Two younger patients had malignant tumors several years post-SRS, with one patient having confirmed histological transformation.

Conclusions: SRS is equally effective for younger and older patients. Complications other than hearing deterioration are uncommon. However, malignant transformation is possible, and long-term post-SRS surveillance MRI is important. These data are useful for decision-making involving young adults with VSs.

Keywords: Gamma knife; Matched cohort analysis; Stereotactic radiosurgery; Vestibular schwannoma; Younger patients.

MeSH terms

  • Follow-Up Studies
  • Hearing Loss / etiology
  • Humans
  • Neuroma, Acoustic* / radiotherapy
  • Radiosurgery* / adverse effects
  • Treatment Outcome
  • Young Adult